EUVIMEDEUVIMED entdecken
Crossref

Clinicopathological characteristics of mucinous breast cancer: a retrospective analysis of a 6-years study from national cancer center in Vietnam

Thi Huyen Phung, Thanh Tung Pham, Huu Thang Nguyen, Dinh Thach Nguyen, Thanh Long Nguyen, Thi Hoai Hoang

Breast Cancer Research and Treatment · 2025

DOI: 10.1007/s10549-024-07529-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2025. Verfasst von Thi Huyen Phung und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Hanoi Medical University, Hanoi, Vietnam. Hauptthemen laut MEDLINE: Breast Neoplasms, Adenocarcinoma, Mucinous. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate clinicopathological features in women with mucinous breast cancer (MBC), distinguishing between pure (PMC) and mixed (MMC) subtype. METHODS: A retrospective analysis of all 358 women with MBC treated at Vietnam National Cancer hospital from June 2015 to December 2020. PMC was defined by ≥ 90% mucinous components. RESULTS: We identified 358 women with MBC (245 PMC and 113 MMC) representing 2.7% of all 13,254 BC patients. The proportions of stage I, II, III and IV were 34.9%, 50.8%, 10.4% and 3.9% respectively. The rate of HER2 overexpression was 12%, and only 1.4% of patients was treated with anti-HER2. 193 patients (53.9%) had chemotherapy, including 55 patients (15.4%) treated in the neoadjuvant setting. Only 3 patients (5.5%) achieved pCR. PMC patients were older (54.4 ± 13.3 vs 51.1 ± 13.1 years), had lower Ki67 expression, lower incidence of nodal metastasis (N +) (p values < 0.05). At a median follow-up of 58 months, the 5-year overall survival rate of non-metastatic patients was 86.6%. Multivariate analysis showed N + to be the most significant prognostic factor (HR = 3.3; 95%CI 1.5-7.1), followed by T-stage (HR = 2.9; 95%CI 1.4-6.3), HER2 + (HR = 2.5; 95%CI 1.2-5.3) and MMC subtype (HR = 1.9; 95%CI 1.0-3.9). CONCLUSION: Poor prognostic factors of MBC include high T-stage, N-positivity, HER2 overexpression and MMC subtype. Given the low response rate to neoadjuvant CT, upfront surgery is appropriate for MBC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAdenocarcinoma, MucinousHumansFemaleMiddle AgedRetrospective StudiesVietnamAdultAgedErb-b2 Receptor Tyrosine KinasesNeoplasm StagingPrognosisNeoadjuvant TherapyBiomarkers, Tumor

Stichwörter der Autor:innen

Chemotherapy (CT)Mixed mucinous carcinoma (MMC)Mucinous breast cancer (MBC)Pure mucinous carcinoma (PMC)

Substanzen

Erb-b2 Receptor Tyrosine KinasesBiomarkers, TumorERBB2 protein, human

Autor:innen und Institutionen

  • Department of Oncology, Hanoi Medical University, Hanoi, Vietnam.
  • Department of Medical Oncology 6, Vietnam National Cancer Hospital, Hanoi, Vietnam.
  • Department of Pathology, Vietnam National Cancer Hospital, Hanoi, Vietnam.
  • Department of Oncology, Hanoi Medical University, Hanoi, Vietnam. hoanghoaihmu@gmail.com.
  • Department of Medical Oncology 6, Vietnam National Cancer Hospital, Hanoi, Vietnam. hoanghoaihmu@gmail.com.

Zitieren

APA

Phung, T. H., Pham, T. T., Nguyen, H. T., Nguyen, D. T., Nguyen, T. L., & Hoang, T. H. (2025). Clinicopathological characteristics of mucinous breast cancer: a retrospective analysis of a 6-years study from national cancer center in Vietnam. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07529-x

Vancouver

Phung TH, Pham TT, Nguyen HT, Nguyen DT, Nguyen TL, Hoang TH. Clinicopathological characteristics of mucinous breast cancer: a retrospective analysis of a 6-years study from national cancer center in Vietnam. Breast Cancer Research and Treatment. 2025. doi:10.1007/s10549-024-07529-x

BibTeX
@article{Phung2025,
  author = {Phung, Thi Huyen and Pham, Thanh Tung and Nguyen, Huu Thang and Nguyen, Dinh Thach and Nguyen, Thanh Long and Hoang, Thi Hoai},
  title = {Clinicopathological characteristics of mucinous breast cancer: a retrospective analysis of a 6-years study from national cancer center in Vietnam},
  journal = {Breast Cancer Research and Treatment},
  year = {2025},
  doi = {10.1007/s10549-024-07529-x}
}
Kostenlos starten →